​

Fortress Biotech (FBIO) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

FBIO Stock Rating

Fortress Biotech stock's rating consensus is Buy, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 6 0 6 Strong Sell Sell Hold Buy Strong Buy

FBIO Price Target Upside V Benchmarks

TypeNameUpside
StockFortress Biotech-
SectorHealthcare Stocks 23.68%
IndustryBiotech Stocks 64.77%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$1.96$1.96$1.96
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 2511---2
May, 2521---3
Apr, 2521---3
Mar, 2521---3
Feb, 2521---3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Apr 09, 2024H.C. WainwrightBuyBuyhold
Jul 14, 2022B. Riley SecuritiesBuyBuyhold
Apr 26, 2022Zacks Investment ResearchStrong Selldowngrade

Financial Forecast

EPS Forecast

$-40 $-31 $-22 $-13 $-4 $5 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-21.45$-30.26$-36.10$-8.47$-5.81---
Avg Forecast$-10.90$-5.50$-13.13$-7.75$-3.51$-1.48$-0.42$-0.46
High Forecast$-8.07$-4.07$-9.70$-5.42$-2.45$-1.14$0.23$-0.32
Low Forecast$-13.73$-6.93$-16.55$-10.20$-4.62$-1.81$-1.07$-0.61
Surprise %96.79%450.18%174.94%9.29%65.53%---

Revenue Forecast

$0 $50M $100M $150M $200M $250M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$45.60M$68.79M$75.74M$84.51M$55.13M---
Avg Forecast$43.83M$89.50M$77.97M$79.70M$58.87M$134.53M$198.39M$198.80M
High Forecast$52.57M$107.35M$93.61M$99.15M$59.30M$156.02M$246.81M$247.32M
Low Forecast$35.09M$71.65M$62.33M$61.27M$58.42M$113.04M$152.53M$152.84M
Surprise %4.03%-23.14%-2.86%6.04%-6.34%---

Net Income Forecast

$-250M $-190M $-130M $-70M $-10M $50M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-102.98M$-164.83M$-213.91M$-60.64M$-120.86M---
Avg Forecast$-88.41M$-44.61M$-106.46M$-68.67M$-28.68M$-11.98M$-3.41M$-3.76M
High Forecast$-65.49M$-33.05M$-78.70M$-43.94M$-19.89M$-9.26M$1.87M$-2.61M
Low Forecast$-111.33M$-56.17M$-134.21M$-82.75M$-37.47M$-14.69M$-8.68M$-4.91M
Surprise %16.49%269.48%100.94%-11.70%321.38%---

FBIO Forecast FAQ

Is Fortress Biotech stock a buy?

Fortress Biotech stock has a consensus rating of Buy, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Fortress Biotech is a favorable investment for most analysts.

What is Fortress Biotech's price target?

Fortress Biotech's price target, set by 6 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $1.96.

How does Fortress Biotech stock forecast compare to its benchmarks?

Fortress Biotech's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (23.68%) and underperforming the biotech stocks industry (64.77%).

What is the breakdown of analyst ratings for Fortress Biotech over the past three months?

  • June 2025: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 66.67% Strong Buy, 33.33% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 66.67% Strong Buy, 33.33% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Fortress Biotech’s EPS forecast?

Fortress Biotech's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.48, marking a -74.53% decrease from the reported $-5.81 in 2024. Estimates for the following years are $-0.42 in 2026, and $-0.46 in 2027.

What is Fortress Biotech’s revenue forecast?

Fortress Biotech's average annual revenue forecast for its fiscal year ending in December 2025 is $134.53M, reflecting a 144.01% increase from the reported $55.13M in 2024. The forecast for 2026 is $198.39M, and $198.8M for 2027.

What is Fortress Biotech’s net income forecast?

Fortress Biotech's net income forecast for the fiscal year ending in December 2025 stands at $-11.978M, representing a -90.09% decrease from the reported $-121M in 2024. Projections indicate $-3.407M in 2026, and $-3.762M in 2027.